Zimmer Financial Statements From 2010 to 2024

ZBH Stock  USD 112.10  0.08  0.07%   
Zimmer Biomet financial statements provide useful quarterly and yearly information to potential Zimmer Biomet Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Zimmer Biomet financial statements helps investors assess Zimmer Biomet's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Zimmer Biomet's valuation are summarized below:
Gross Profit
4.9 B
Profit Margin
0.1427
Market Capitalization
22.3 B
Enterprise Value Revenue
3.7285
Revenue
7.6 B
We have found one hundred twenty available fundamental gauges for Zimmer Biomet Holdings, which can be analyzed and compared to other ratios and to its peers. Traders should compare all of Zimmer Biomet Holdings prevalent fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year.

Zimmer Biomet Total Revenue

4.96 Billion

Check Zimmer Biomet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zimmer Biomet's main balance sheet or income statement drivers, such as Depreciation And Amortization of 999.3 M, Interest Expense of 141.5 M or Selling General Administrative of 2 B, as well as many indicators such as Price To Sales Ratio of 4.51, Dividend Yield of 0.0157 or PTB Ratio of 1.93. Zimmer financial statements analysis is a perfect complement when working with Zimmer Biomet Valuation or Volatility modules.
  
Check out the analysis of Zimmer Biomet Correlation against competitors.

Zimmer Biomet Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding164.9 M209.7 M194 M
Slightly volatile
Total Assets13.7 B21.5 B18 B
Slightly volatile
Other Current LiabilitiesB1.4 B1.3 B
Slightly volatile
Total Current Liabilities1.5 B2.9 BB
Slightly volatile
Total Stockholder Equity7.4 B12.5 B9.1 B
Slightly volatile
Property Plant And Equipment Net1.4 B2.3 B1.6 B
Slightly volatile
Accounts Payable229.9 M410.6 M274.2 M
Slightly volatile
Non Current Assets Total10.3 B16.9 B13.9 B
Slightly volatile
Non Currrent Assets Other577.3 M916.7 M801.1 M
Slightly volatile
Net Receivables975.8 M1.4 B1.2 B
Slightly volatile
Liabilities And Stockholders Equity13.7 B21.5 B18 B
Slightly volatile
Non Current Liabilities Total4.8 B6.2 BB
Slightly volatile
Inventory1.4 B2.4 B1.7 B
Slightly volatile
Other Current Assets401.6 M366.1 M465.1 M
Slightly volatile
Total Liabilities6.3 BBB
Slightly volatile
Property Plant And Equipment Gross7.1 B6.8 B2.9 B
Slightly volatile
Total Current Assets3.4 B4.6 B4.2 B
Slightly volatile
Other Liabilities1.2 B1.3 B1.6 B
Pretty Stable
Other Assets1.4 B1.3 B717.7 M
Slightly volatile
Property Plant Equipment1.4 B2.2 B1.7 B
Slightly volatile
Short and Long Term Debt Total4.8 BB6.7 B
Pretty Stable
Net Debt3.7 B5.6 B5.2 B
Slightly volatile
Retained Earnings6.8 B10.4 B8.2 B
Slightly volatile
Cash591.2 M415.8 M678 M
Pretty Stable
Long Term DebtBB5.3 B
Slightly volatile
Cash And Short Term Investments732.9 M415.8 M862.8 M
Slightly volatile
Common Stock Total Equity2.9 M3.6 M2.9 M
Slightly volatile
Short Term Debt1.3 B952.9 M1.4 B
Very volatile
Common StockM3.2 M2.9 M
Slightly volatile
Good WillB8.8 B6.9 B
Slightly volatile
Intangible Assets4.2 B4.9 B4.9 B
Slightly volatile
Retained Earnings Total Equity9.1 B11 B8.7 B
Slightly volatile
Capital Surpluse7.5 B10.9 B7.2 B
Slightly volatile
Non Current Liabilities OtherB652.2 M963.4 M
Slightly volatile
Long Term Debt Total6.5 B5.9 B5.6 B
Slightly volatile
Long Term Investments73.1 M69.6 M37.2 M
Slightly volatile
Short and Long Term Debt1.5 B900 M1.4 B
Very volatile
Cash And Equivalents454.3 M338.1 M571.5 M
Slightly volatile
Net Invested Capital13 B18.4 B18.7 B
Slightly volatile
Net Working CapitalB1.8 B1.7 B
Slightly volatile
Capital Stock3.4 M3.2 M3.1 M
Slightly volatile

Zimmer Biomet Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization999.3 M951.7 M470.3 M
Slightly volatile
Selling General AdministrativeB2.8 B2.5 B
Slightly volatile
Total RevenueB7.4 BB
Slightly volatile
Gross Profit3.6 B5.3 B4.3 B
Slightly volatile
Other Operating Expenses3.9 B6.1 B4.8 B
Slightly volatile
Operating Income853 M1.3 B818.7 M
Pretty Stable
Research Development259 M458.7 M311.1 M
Slightly volatile
EBITDA1.6 B2.2 B1.8 B
Slightly volatile
Cost Of Revenue1.4 B2.1 B1.7 B
Slightly volatile
Total Operating Expenses2.5 BB3.1 B
Slightly volatile
Selling And Marketing Expenses124.7 M181.5 M151.3 M
Slightly volatile
Non Recurring410.1 M336.7 M363.6 M
Pretty Stable
Interest Income148.5 M189.5 M177.3 M
Slightly volatile
Reconciled Depreciation808.5 M939 MB
Slightly volatile

Zimmer Biomet Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow912.5 M1.2 B1.1 B
Slightly volatile
Begin Period Cash Flow602.2 M375.7 M737.7 M
Slightly volatile
Depreciation514 M951.7 M714.5 M
Slightly volatile
Capital Expenditures632.9 M602.8 M227.9 M
Slightly volatile
Total Cash From Operating Activities1.1 B1.6 B1.2 B
Slightly volatile
End Period Cash Flow596.1 M415.8 M720 M
Slightly volatile
Stock Based Compensation74.8 M99.8 M68.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.513.4353.5681
Very volatile
Dividend Yield0.01570.00790.0144
Slightly volatile
PTB Ratio1.932.03512.9497
Slightly volatile
Days Sales Outstanding55.3471.201270.7806
Slightly volatile
Book Value Per Share62.8359.83847.6503
Slightly volatile
Free Cash Flow Yield0.04130.04740.0551
Slightly volatile
Operating Cash Flow Per Share3.937.57836.2239
Slightly volatile
Stock Based Compensation To Revenue0.0130.01350.0112
Very volatile
Capex To Depreciation0.810.63340.369
Pretty Stable
PB Ratio1.932.03512.9497
Slightly volatile
EV To Sales4.924.18954.2574
Slightly volatile
Free Cash Flow Per Share3.265.76955.312
Pretty Stable
ROIC0.06390.06720.0889
Slightly volatile
Inventory Turnover1.290.87361.0846
Slightly volatile
Days Of Inventory On Hand262418348
Slightly volatile
Payables Turnover4.865.0756.2631
Pretty Stable
Sales General And Administrative To Revenue0.450.520.4261
Slightly volatile
Research And Ddevelopement To Revenue0.04160.0620.0503
Slightly volatile
Capex To Revenue0.04610.08150.0333
Pretty Stable
Cash Per Share2.781.99234.5765
Slightly volatile
POCF Ratio20.8116.058917.3071
Pretty Stable
Interest Coverage6.036.35049.2814
Slightly volatile
Capex To Operating Cash Flow0.20.38110.1568
Slightly volatile
PFCF Ratio25.6121.093620.3414
Pretty Stable
Days Payables Outstanding69.9671.92162.3006
Very volatile
EV To Operating Cash Flow23.0719.586621.2982
Pretty Stable
EV To Free Cash Flow28.4525.727325.2856
Pretty Stable
Intangibles To Total Assets0.450.63610.5717
Slightly volatile
Net Debt To EBITDA1.682.51973.1442
Slightly volatile
Current Ratio2.851.61322.5749
Slightly volatile
Receivables Turnover5.895.12635.1721
Slightly volatile
Graham Number85.3181.252154.9511
Slightly volatile
Shareholders Equity Per Share62.7959.801147.6402
Slightly volatile
Debt To Equity0.670.46220.8822
Slightly volatile
Capex Per Share3.032.88841.1412
Slightly volatile
Revenue Per Share17.7935.429829.915
Slightly volatile
Interest Debt Per Share15.9728.601329.9053
Slightly volatile
Debt To Assets0.180.26830.3004
Very volatile
Enterprise Value Over EBITDA12.7313.990116.4171
Pretty Stable
Short Term Coverage Ratios1.671.7573132
Pretty Stable
Operating Cycle317489419
Slightly volatile
Price Book Value Ratio1.932.03512.9497
Slightly volatile
Days Of Payables Outstanding69.9671.92162.3006
Very volatile
Price To Operating Cash Flows Ratio20.8116.058917.3071
Pretty Stable
Price To Free Cash Flows Ratio25.6121.093620.3414
Pretty Stable
Operating Profit Margin0.220.17280.1563
Slightly volatile
Company Equity Multiplier2.281.72241.9447
Slightly volatile
Long Term Debt To Capitalization0.220.28060.3555
Pretty Stable
Total Debt To Capitalization0.230.31610.3801
Pretty Stable
Return On Capital Employed0.06510.06850.0999
Slightly volatile
Debt Equity Ratio0.670.46220.8822
Slightly volatile
Ebit Per Revenue0.220.17280.1563
Slightly volatile
Quick Ratio0.740.77841.5534
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.871.96793.9346
Slightly volatile
Net Income Per E B T0.810.95941.2462
Very volatile
Cash Ratio0.140.14550.4432
Slightly volatile
Cash Conversion Cycle266417358
Slightly volatile
Operating Cash Flow Sales Ratio0.250.21390.2136
Pretty Stable
Days Of Inventory Outstanding262418348
Slightly volatile
Days Of Sales Outstanding55.3471.201270.7806
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.660.76130.8434
Slightly volatile
Cash Flow Coverage Ratios0.260.27420.3306
Slightly volatile
Price To Book Ratio1.932.03512.9497
Slightly volatile
Fixed Asset Turnover4.943.26574.0248
Slightly volatile
Capital Expenditure Coverage Ratio2.492.62387.4717
Slightly volatile
Price Cash Flow Ratio20.8116.058917.3071
Pretty Stable
Enterprise Value Multiple12.7313.990116.4171
Pretty Stable
Debt Ratio0.180.26830.3004
Very volatile
Cash Flow To Debt Ratio0.260.27420.3306
Slightly volatile
Price Sales Ratio4.513.4353.5681
Very volatile
Asset Turnover0.680.3440.4617
Slightly volatile
Gross Profit Margin0.80.71820.7213
Pretty Stable
Price Fair Value1.932.03512.9497
Slightly volatile

Zimmer Biomet Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap12.9 B14.6 B15.8 B
Slightly volatile
Enterprise Value12.8 B14.4 B15.7 B
Slightly volatile

Zimmer Fundamental Market Drivers

Forward Price Earnings13.0719
Cash And Short Term Investments415.8 M

Zimmer Upcoming Events

8th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Zimmer Biomet Financial Statements

Investors use fundamental indicators, such as Zimmer Biomet's revenue or net income, to determine how well the company is positioned to perform in the future. Although Zimmer Biomet's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue-30.4 M-31.9 M
Total Revenue7.4 BB
Cost Of Revenue2.1 B1.4 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.52  0.45 
Research And Ddevelopement To Revenue 0.06  0.04 
Capex To Revenue 0.08  0.05 
Revenue Per Share 35.43  17.79 
Ebit Per Revenue 0.17  0.22 

Currently Active Assets on Macroaxis

When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:
Check out the analysis of Zimmer Biomet Correlation against competitors.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.597
Dividend Share
0.96
Earnings Share
5.24
Revenue Per Share
37.006
Quarterly Revenue Growth
0.04
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.